Active, not recruitingPHASE1, PHASE2NCT06475495

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis

Studying NON RARE IN EUROPE: Rheumatoid arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Charite University, Berlin, Germany
Principal Investigator
David Simon, Professor Dr. med.
Charite University, Berlin, Germany
Intervention
KYV101(drug)
Enrollment
13 target
Eligibility
18-80 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

Kyverna Therapeutics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06475495 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Rheumatoid arthritis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Rheumatoid arthritis

← Back to all trials